Mycronic (MYCR) Aperçu de l'action
Mycronic AB (publ) développe, fabrique et vend des équipements de production pour l'industrie électronique en Suède, dans le reste de l'Europe, aux États-Unis, dans les autres Amériques, en Chine, en Corée du Sud, dans le reste de l'Asie et au niveau international. Plus de détails
| Score flocon de neige | |
|---|---|
| Évaluation | 1/6 |
| Croissance future | 4/6 |
| Performances passées | 3/6 |
| Santé financière | 6/6 |
| Dividendes | 0/6 |
Récompenses
Analyse des risques
MYCR ont passé avec succès nos contrôles de risques.
MYCR Community Fair Values
Create NarrativeSee what 19 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Top Community Narratives
Mycronic
37.8% surévalué décote intrinsèque
Historically Cheap, but the Margin of Safety Is Still Thin
View narrativeMA
Published 18 Jun 2025
Mycronic AB (publ) Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | SEK 320.40 |
| Plus haut sur 52 semaines | SEK 353.20 |
| Plus bas sur 52 semaines | SEK 183.32 |
| Bêta | 0.70 |
| Variation sur 1 mois | -1.96% |
| Variation sur 3 mois | 4.64% |
| Variation sur 1 an | 51.24% |
| Variation sur 3 ans | 193.68% |
| Variation sur 5 ans | 160.28% |
| Évolution depuis l'introduction en bourse | 211.82% |
Nouvelles et mises à jour récentes
Mise à jour du récit • Sep 03
MYCR: Upgraded Rating And Raised Guidance Will Eventually Confront Rich Pricing
Analysts have lifted their price target for Mycronic to SEK 385, with an implied fair value move from SEK 211 to SEK 230. This reflects updated assumptions on discount rate, revenue growth, profit margin and future P/E, and it aligns with recent Street research where the stock was upgraded to Buy.
Mise à jour du récit • Aug 17
MYCR: Upgraded Rating And 2026 Guidance Will Drive Revaluation Potential
Analysts have raised their price target on Mycronic from SEK 320 to SEK 385, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E multiples. What’s in the News for Mycronic Mycronic issued updated guidance for 2026.Mise à jour du récit • Aug 03
MYCR: Higher Guidance And Orders Will Face Lower Margin Pressure
Analysts have lifted their price target for Mycronic from SEK 161 to SEK 211, citing updated assumptions on growth, margins and P/E multiples, along with recent supportive Street research that includes a SEK 385 target. What’s in the News for Mycronic Mycronic received an SLX mask writer order from an existing customer in Asia, valued between US$5 million and US$7 million, with delivery planned for the second quarter of 2027.
Mise à jour du récit • Jul 20
MYCR: Mixed Rating Shifts And Guidance Reset Will Shape Future Upside Potential
Analysts have raised their fair value estimate for Mycronic from SEK 260.25 to SEK 311.50, citing updated assumptions around revenue growth, profit margins, and a lower expected future P/E multiple, in the context of recent mixed broker views including a SEK 385 target from SEB Equities. Analyst Commentary Analyst views on Mycronic are mixed, with some taking a more constructive stance on the stock while others have turned more cautious.Recent updates
Mise à jour du récit • Sep 03
MYCR: Upgraded Rating And Raised Guidance Will Eventually Confront Rich Pricing
Analysts have lifted their price target for Mycronic to SEK 385, with an implied fair value move from SEK 211 to SEK 230. This reflects updated assumptions on discount rate, revenue growth, profit margin and future P/E, and it aligns with recent Street research where the stock was upgraded to Buy.Mise à jour du récit • Aug 17
MYCR: Upgraded Rating And 2026 Guidance Will Drive Revaluation Potential
Analysts have raised their price target on Mycronic from SEK 320 to SEK 385, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E multiples. What’s in the News for Mycronic Mycronic issued updated guidance for 2026.Mise à jour du récit • Aug 03
MYCR: Higher Guidance And Orders Will Face Lower Margin Pressure
Analysts have lifted their price target for Mycronic from SEK 161 to SEK 211, citing updated assumptions on growth, margins and P/E multiples, along with recent supportive Street research that includes a SEK 385 target. What’s in the News for Mycronic Mycronic received an SLX mask writer order from an existing customer in Asia, valued between US$5 million and US$7 million, with delivery planned for the second quarter of 2027.Mise à jour du récit • Jul 20
MYCR: Mixed Rating Shifts And Guidance Reset Will Shape Future Upside Potential
Analysts have raised their fair value estimate for Mycronic from SEK 260.25 to SEK 311.50, citing updated assumptions around revenue growth, profit margins, and a lower expected future P/E multiple, in the context of recent mixed broker views including a SEK 385 target from SEB Equities. Analyst Commentary Analyst views on Mycronic are mixed, with some taking a more constructive stance on the stock while others have turned more cautious.Mise à jour du récit • Jul 06
MYCR: Cautious Ratings And New Orders Will Shape Execution Focus
The analyst price target for Mycronic has been revised from SEK 255 to SEK 320, with analysts citing updated assumptions for revenue growth, profit margins and future P/E as they reassess the stock following a series of more cautious rating changes from SEB Equities, Nordea and DNB Carnegie. Analyst Commentary Recent commentary on Mycronic reflects a more cautious tone from several firms, yet the higher SEK 320 price target signals that some bullish analysts still see room for upside if the company delivers on the updated assumptions for revenue, margins and P/E.Mise à jour du récit • Jun 22
MYCR: Sector Downgrades And Execution Risks Will Restrain Future Upside
The latest Narrative Update on Mycronic reflects a reduced analyst price target of SEK260.25, as analysts factor in slightly lower revenue growth and profit margin assumptions, along with a modestly higher future P/E, in the context of several recent downgrades on the stock. Analyst Commentary Recent research on Mycronic points to a more cautious stance among several bearish analysts, who have downgraded the stock while reassessing revenue growth, margins, and valuation multiples.Article d’analyse • Jun 19
Mycronic (OM:MYCR) Stock Could Be 17.2% Overvalued After New SLX Order
Mycronic (OM:MYCR) stock is back in focus after the company reported a new European customer order for its SLX laser mask writer, valued at US$6 to 8 million with delivery planned in Q3 2026. See our latest analysis for Mycronic. The SLX order lands at a time when Mycronic’s short term share price momentum has been firm, with a 90 day share price return of 44.34%. The 1 year total shareholder return of 70.93% and 3 year total shareholder return of 151.03% point to strong long term...Mise à jour du récit • Jun 07
MYCR: Sector Downgrades And Higher Risk Perceptions Will Pressure Future Upside
Analysts have trimmed their stance on Mycronic, nudging the SEK 260.25 price target lower in line with a slightly higher discount rate and more cautious sector views following several recent rating downgrades. Analyst Commentary Recent research has taken a more cautious tone on Mycronic, with several downgrades pointing to higher required returns and more conservative sector assumptions feeding into valuation work.Mise à jour du récit • May 09
MYCR: Clustered Downgrades And Extended Deliveries Will Pressure Near Term Upside
The updated analyst price target for Mycronic has shifted from SEK 226.50 to SEK 260.25. Analysts cite changes in growth expectations and valuation assumptions, even as several firms have recently turned more cautious on the stock.Article d’analyse • Apr 29
Mycronic AB (publ) Just Missed Earnings - But Analysts Have Updated Their Models
It's been a good week for Mycronic AB (publ) ( STO:MYCR ) shareholders, because the company has just released its...Mise à jour du récit • Apr 24
MYCR: Extended Delivery Timeline For New Orders Will Restrain Near-Term Upside
Analysts have raised their price target on Mycronic to SEK226.50 from SEK213.67, reflecting updated views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions. What's in the News Order for a customized SLX mask writer from a new customer, valued between US$27 million and US$30 million, with delivery planned in 2028.Mise à jour du récit • Apr 09
MYCR: Asian Equipment Orders And 2026 Outlook Will Support Steady Dividend Profile
Analysts have slightly adjusted their price target on Mycronic from SEK 215 to about SEK 214. This reflects updated assumptions around discount rates, revenue growth, profit margins and future P/E multiples, while keeping their overall view broadly consistent.Mise à jour du récit • Mar 26
MYCR: Asian Orders And 2026 Guidance Will Underpin Stable Dividend Outlook
Analysts are maintaining their SEK 215.0 price target for Mycronic, noting only minor adjustments to inputs such as the discount rate, long-term revenue, profit margin and future P/E assumptions that do not materially change their valuation view. What's in the News Mycronic has issued earnings guidance for 2026, indicating expected net sales of SEK 8.25b for the period (Corporate Guidance).Mise à jour du récit • Mar 09
MYCR: Asian Orders And 2026 Guidance Will Support Steady Dividend Outlook
Analysts have maintained their SEK 215.00 price target for Mycronic. This reflects minor adjustments to assumptions regarding the discount rate, long-term growth and P/E, which did not meaningfully change their overall view of the shares.Mise à jour du récit • Feb 22
MYCR: Asian Orders And 2026 Guidance Will Shape Balanced Outlook
Analysts now keep their SEK 215.0 price target for Mycronic broadly unchanged, with slight adjustments in the discount rate, revenue growth expectations, profit margin assumptions, and future P/E multiples shaping the latest narrative update. What's in the News Mycronic issued earnings guidance for 2026, indicating expected net sales of SEK 8.25b for the period (company guidance).Article d’analyse • Feb 08
Analyst Estimates: Here's What Brokers Think Of Mycronic AB (publ) (STO:MYCR) After Its Full-Year Report
Mycronic AB (publ) ( STO:MYCR ) shareholders are probably feeling a little disappointed, since its shares fell 6.9% to...Mise à jour du récit • Feb 08
MYCR: Asian Orders And Higher Margins Will Support Bullish Outlook
Analysts have trimmed their price target on Mycronic to SEK215 from about SEK218.67, citing updated assumptions that include a slightly higher discount rate, adjusted revenue growth and profit margin expectations, and a lower future P/E multiple. What's in the News Mycronic announced an annual dividend of SEK 3.25 per share, with an ex dividend date set for May 7, 2026, a record date on May 8, 2026, and a payment date on May 13, 2026 (company announcement).Mise à jour du récit • Jan 24
MYCR: Asian Orders And Cautious Margins Will Support Stable Outlook
Analysts have kept their overall price target for Mycronic unchanged at SEK 218.67, with adjustments in the discount rate, profit margin and future P/E assumptions reflecting a more cautious margin outlook, offset by support from valuation multiples. What's in the News Mycronic received an order for an MMX metrology system from a new customer in Asia, valued in the range of US$2 million to US$4 million, with delivery planned for the current quarter (company announcement).Article d’analyse • Jan 23
Mycronic (STO:MYCR) Is Reinvesting To Multiply In Value
What are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...Mise à jour du récit • Jan 08
MYCR: Asian Equipment Orders And Higher Margins Will Support Steady Outlook
Analysts have left their fair value estimate for Mycronic unchanged at SEK 218.67. The latest price target is shaped mainly by slightly revised assumptions on discount rate, revenue growth, profit margin and future P/E, which together reflect a more balanced view of the company’s earnings profile and valuation risk.Article d’analyse • Dec 31
Estimating The Fair Value Of Mycronic AB (publ) (STO:MYCR)
Key Insights Mycronic's estimated fair value is kr215 based on 2 Stage Free Cash Flow to Equity Current share price of...Mise à jour du récit • Dec 13
MYCR: Expanding Asian Orders Will Support Steady Earnings And Balanced Prospects
Analysts have nudged their price target for Mycronic slightly higher to approximately SEK 219 per share, reflecting modestly increased discount rate and future P E assumptions, while maintaining a generally stable view on long term revenue growth and profitability. What's in the News Mycronic secured a new Asian customer for its SLX semiconductor mask writer, an energy efficient system with an order value between USD 5 million and 7 million, with revenue recognized in the current quarter (company announcement).Mise à jour du récit • Nov 27
MYCR: Growing Asian Orders And Margins Will Support Measured Gains Through 2025
Analysts have slightly increased their price target for Mycronic to SEK 218.67 from SEK 217.33. They cite improved revenue growth expectations and a marginally higher projected profit margin.Mise à jour du récit • Nov 07
MYCR: Net Profit Margins And Orders Will Support Steady Outlook Through 2025
Analysts have slightly raised their price target for Mycronic from SEK 216.67 to SEK 217.33. They cite improved profit margin forecasts and a more favorable future price-to-earnings outlook.Article d’analyse • Oct 28
Mycronic AB (publ) Just Beat Revenue Estimates By 9.4%
Mycronic AB (publ) ( STO:MYCR ) just released its quarterly report and things are looking bullish. The company beat...Mise à jour du récit • Oct 24
Upcoming Orders and Expansion Will Drive Global Technology Reach Forward
Analyst Price Target Update for Mycronic Analysts have raised their fair value estimate for Mycronic from SEK 207.00 to SEK 216.67. This update reflects improved revenue growth projections, even though there is a slightly higher discount rate and lower profit margin expectations.Mise à jour du récit • Oct 10
Acquisitions And Launches Will Expand Global Technology Reach
Narrative Update on Mycronic: Analyst Price Target Revision Analysts have revised their price target for Mycronic downward by SEK 31, from SEK 238 to SEK 207. This adjustment is based on updated forecasts for slower revenue growth and slightly softer profit margins.Article d’analyse • Sep 19
Estimating The Fair Value Of Mycronic AB (publ) (STO:MYCR)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Mycronic fair value estimate is kr235 With kr220 share price...Mise à jour du récit • Aug 27
Acquisitions And Launches Will Expand Global Technology Reach
The increase in Mycronic's consensus price target to SEK238.00 reflects improved revenue growth forecasts and a modestly higher future P/E multiple. What's in the News Mycronic updated its 2025 revenue guidance, reverting to its original estimate of SEK 7.5 billion in net sales, compared to the previous range of SEK 7.0 to 7.5 billion.
Nouveau récit • Jun 24
Historically Cheap, but the Margin of Safety Is Still Thin
Electronics-complexity super-cycle — AI datacentres, EVs and advanced display / semiconductor nodes require ever-finer photomasks, ultra-precise die bonding and higher-reliability SMT lines, directlyRendement pour les actionnaires
| MYCR | SE Electronic | SE Marché | |
|---|---|---|---|
| 7D | 2.3% | -1.1% | -1.4% |
| 1Y | 51.2% | -2.6% | 12.0% |
Rendement vs Industrie: MYCR a dépassé le secteur Swedish Electronic qui a rapporté -2.6 % au cours de l'année écoulée.
Rendement vs marché: MYCR a dépassé le marché Swedish qui a rapporté 12 % au cours de l'année écoulée.
Volatilité des prix
| MYCR volatility | |
|---|---|
| MYCR Average Weekly Movement | 6.4% |
| Electronic Industry Average Movement | 6.2% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in SE Market | 10.9% |
| 10% least volatile stocks in SE Market | 2.9% |
Cours de l'action stable: MYCR n'a pas connu de volatilité de prix significative au cours des 3 derniers mois par rapport au marché Swedish.
Volatilité au fil du temps: La volatilité hebdomadaire de MYCR ( 6% ) est restée stable au cours de l'année écoulée.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 1989 | 2,772 | Anders Lindqvist | www.mycronic.com |
Mycronic AB (publ) développe, fabrique et vend des équipements de production pour l'industrie électronique en Suède, dans le reste de l'Europe, aux États-Unis, dans les autres Amériques, en Chine, en Corée du Sud, dans le reste de l'Asie et au niveau international. Elle opère à travers quatre segments : Générateurs de modèles, Haute flexibilité, Grand volume et Technologies globales. Le segment Pattern Generators développe, fabrique et commercialise des machines à écrire et à mesurer les masques pour la production de photomasques avancés destinés à la fabrication d'écrans de télévision, de voitures, de téléphones portables, de tablettes et d'ordinateurs, ainsi que de composants semi-conducteurs.
Mycronic AB (publ) Résumé des fondamentaux
| MYCR statistiques fondamentales | |
|---|---|
| Capitalisation boursière | SEK 62.56b |
| Bénéfices(TTM) | SEK 1.74b |
| Recettes(TTM) | SEK 8.65b |
36.1x
Ratio P/E7.2x
Ratio P/SLe site MYCR est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| MYCR compte de résultat (TTM) | |
|---|---|
| Recettes | SEK 8.65b |
| Coût des recettes | SEK 3.97b |
| Marge brute | SEK 4.68b |
| Autres dépenses | SEK 2.95b |
| Les revenus | SEK 1.74b |
Derniers bénéfices déclarés
Jun 30, 2026
Prochaine date de publication des résultats
Oct 22, 2026
| Résultat par action (EPS) | 8.89 |
| Marge brute | 54.11% |
| Marge bénéficiaire nette | 20.06% |
| Ratio dettes/capitaux propres | 3.6% |
Quelles ont été les performances à long terme de MYCR?
Voir les performances historiques et les comparaisonsDividendes
1.0%
Rendement actuel des dividendes37%
Ratio de distributionAnalyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/09/11 00:16 |
| Cours de l'action en fin de journée | 2026/09/11 00:00 |
| Les revenus | 2026/06/30 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github ; nous proposons également des guides sur la façon d’utiliser nos rapports et des tutoriels sur YouTube.
Découvrez l' qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Mycronic AB (publ) est couverte par 9 analystes. 3 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Nils Sjogren | ABG Sundal Collier Sponsored |
| Oliver Wong | BofA Global Research |
| Mikael Laséen | Carnegie Investment Bank AB |